Physician profile
Corey Wheelock
NPI 1639795669
$521.43
in general payments reported to CMS, 2019-2025
9 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $128 · 2024: $38.45 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $119.72 | 2025 | Iovera |
| Allergan, INC. | $103.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $98.63 | 2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $57.58 | 2025 | |
| Orthofix Medical, INC. | $42.01 | 2025 | Cervical-Stim |
| Baxter Healthcare | $37.14 | 2025 | Floseal |
| Abbvie INC. | $24.90 | 2022 | |
| Stryker Corporation | $23.39 | 2024 | Variax |
| Ipsen Biopharmaceuticals, INC | $15.06 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Wheelock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.